138 related articles for article (PubMed ID: 23504005)
1. Nucleotides in the eye: focus on functional aspects and therapeutic perspectives.
Guzman-Aranguez A; Santano C; Martin-Gil A; Fonseca B; Pintor J
J Pharmacol Exp Ther; 2013 Jun; 345(3):331-41. PubMed ID: 23504005
[TBL] [Abstract][Full Text] [Related]
2. Dinucleoside polyphosphates in the eye: from physiology to therapeutics.
Guzmán-Aranguez A; Crooke A; Peral A; Hoyle CH; Pintor J
Prog Retin Eye Res; 2007 Nov; 26(6):674-87. PubMed ID: 17931952
[TBL] [Abstract][Full Text] [Related]
3. Nucleotides in ocular secretions: their role in ocular physiology.
Crooke A; Guzmán-Aranguez A; Peral A; Abdurrahman MK; Pintor J
Pharmacol Ther; 2008 Jul; 119(1):55-73. PubMed ID: 18562011
[TBL] [Abstract][Full Text] [Related]
4. Purines in the eye: recent evidence for the physiological and pathological role of purines in the RPE, retinal neurons, astrocytes, Müller cells, lens, trabecular meshwork, cornea and lacrimal gland.
Sanderson J; Dartt DA; Trinkaus-Randall V; Pintor J; Civan MM; Delamere NA; Fletcher EL; Salt TE; Grosche A; Mitchell CH
Exp Eye Res; 2014 Oct; 127():270-9. PubMed ID: 25151301
[TBL] [Abstract][Full Text] [Related]
5. Ion Channels in the Eye: Involvement in Ocular Pathologies.
Giblin JP; Comes N; Strauss O; Gasull X
Adv Protein Chem Struct Biol; 2016; 104():157-231. PubMed ID: 27038375
[TBL] [Abstract][Full Text] [Related]
6. The role of dinucleoside polyphosphates on the ocular surface and other eye structures.
Carracedo G; Crooke A; Guzman-Aranguez A; Pérez de Lara MJ; Martin-Gil A; Pintor J
Prog Retin Eye Res; 2016 Nov; 55():182-205. PubMed ID: 27421962
[TBL] [Abstract][Full Text] [Related]
7. Focus on molecules: diadenosine tetraphosphate.
Guzman-Aranguez A; Loma P; Pintor J
Exp Eye Res; 2011 Feb; 92(2):96-7. PubMed ID: 21163257
[No Abstract] [Full Text] [Related]
8. Immunolocalisation of P2Y receptors in the rat eye.
Pintor J; Sánchez-Nogueiro J; Irazu M; Mediero A; Peláez T; Peral A
Purinergic Signal; 2004 Dec; 1(1):83-90. PubMed ID: 18404404
[TBL] [Abstract][Full Text] [Related]
9. Adenine nucleotides and dinucleotides as new substances for the treatment of ocular hypertension and glaucoma.
Pintor J
Curr Opin Investig Drugs; 2005 Jan; 6(1):76-80. PubMed ID: 15675606
[TBL] [Abstract][Full Text] [Related]
10. An NGF mimetic, MIM-D3, stimulates conjunctival cell glycoconjugate secretion and demonstrates therapeutic efficacy in a rat model of dry eye.
Jain P; Li R; Lama T; Saragovi HU; Cumberlidge G; Meerovitch K
Exp Eye Res; 2011 Oct; 93(4):503-12. PubMed ID: 21726552
[TBL] [Abstract][Full Text] [Related]
11. Four subunits (αβγδ) of the epithelial sodium channel (ENaC) are expressed in the human eye in various locations.
Krueger B; Schlötzer-Schrehardt U; Haerteis S; Zenkel M; Chankiewitz VE; Amann KU; Kruse FE; Korbmacher C
Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):596-604. PubMed ID: 22167092
[TBL] [Abstract][Full Text] [Related]
12. P2X and P2Y purinergic receptors on human intestinal epithelial carcinoma cells: effects of extracellular nucleotides on apoptosis and cell proliferation.
Coutinho-Silva R; Stahl L; Cheung KK; de Campos NE; de Oliveira Souza C; Ojcius DM; Burnstock G
Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G1024-35. PubMed ID: 15662049
[TBL] [Abstract][Full Text] [Related]
13. Muscarinic receptor agonists and antagonists: effects on ocular function.
Mitchelson F
Handb Exp Pharmacol; 2012; (208):263-98. PubMed ID: 22222703
[TBL] [Abstract][Full Text] [Related]
14. A Purinergic Trail for Metastases.
Ferrari D; Malavasi F; Antonioli L
Trends Pharmacol Sci; 2017 Mar; 38(3):277-290. PubMed ID: 27989503
[TBL] [Abstract][Full Text] [Related]
15. Cell culture models of the ocular barriers.
Hornof M; Toropainen E; Urtti A
Eur J Pharm Biopharm; 2005 Jul; 60(2):207-25. PubMed ID: 15939234
[TBL] [Abstract][Full Text] [Related]
16. Improvement of corneal barrier function by the P2Y(2) agonist INS365 in a rat dry eye model.
Fujihara T; Murakami T; Fujita H; Nakamura M; Nakata K
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):96-100. PubMed ID: 11133853
[TBL] [Abstract][Full Text] [Related]
17. Distribution of IGF-I and -II, IGF binding proteins (IGFBPs) and IGFBP mRNA in ocular fluids and tissues: potential sites of synthesis of IGFBPs in aqueous and vitreous.
Arnold DR; Moshayedi P; Schoen TJ; Jones BE; Chader GJ; Waldbillig RJ
Exp Eye Res; 1993 May; 56(5):555-65. PubMed ID: 7684697
[TBL] [Abstract][Full Text] [Related]
18. Connexin43 is required for production of the aqueous humor in the murine eye.
Calera MR; Topley HL; Liao Y; Duling BR; Paul DL; Goodenough DA
J Cell Sci; 2006 Nov; 119(Pt 21):4510-9. PubMed ID: 17046998
[TBL] [Abstract][Full Text] [Related]
19. Focus on molecules: purinergic P2Y(2) receptor.
Guzman-Aranguez A; Pintor J
Exp Eye Res; 2012 Dec; 105():83-4. PubMed ID: 22564973
[No Abstract] [Full Text] [Related]
20. Expression of two molecular forms of the complement decay-accelerating factor in the eye and lacrimal gland.
Lass JH; Walter EI; Burris TE; Grossniklaus HE; Roat MI; Skelnik DL; Needham L; Singer M; Medof ME
Invest Ophthalmol Vis Sci; 1990 Jun; 31(6):1136-48. PubMed ID: 1693916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
